Warning letter
Richard E. Ringel, M.D. [ARCHIVED]: warning letter of May 20, 2009
FDA warning letter 56383 · Center for Devices and Radiological Health
Key facts
| Reference number | 56383 |
|---|---|
| Company | Richard E. Ringel, M.D. [ARCHIVED] |
| Subject | Sponsor-Investigator |
| Issue date | May 20, 2009 |
| Posted date | May 20, 2009 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 812.43(c)(4)(ii), 812.35(a)(4), 812.150(b)(4), 812.40, 812.100, 812, 812.25(b), 812.110(b) |
| Inspection city | Baltimore |
| Inspection ZIP | 21287 |
| Inspection start date | Jan 21, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: